Combination therapy for obesity

J Psychopharmacol
November 2017
https://pubmed.ncbi.nlm.nih.gov/29132230/

Press Release: WAYT-less™ by Nu Image Medical® Exceeds All Projections for Q4 2020

Digital Journal
2021
http://www.digitaljournal.com/pr/4935271

A new online weight loss program that consists of Low Dose Naltrexone, Acarbose, and Orlistat, combined with a low-calorie diet and exercise (optional), works brilliantly to fight obesity and other symptoms.

The Uses of Low-Dose Naltrexone in Clinical Practice

BMJ Case Reports
January 2018
https://www.researchgate.net/publication/328997819_Issue_4_The_Uses_of_Low-Dose_Naltrexone_in_Clinical_Practice

Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis


BMC Medicine
15 January  2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0

Low-dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia (Abstract)

J Biol Chem
27 Nov 2020
https://pubmed.ncbi.nlm.nih.gov/32943552/

 

Deanna Windham, DO - Pediatric and Geriatric Dosing for LDN (2017 Conference) (LDN, low dose naltrexone)

 

Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's Thyroid Presentation

 

Dr Andrey Lev-Weissberg - Weight Loss (2014 Conference) (LDN, low dose naltrexone)

In this presentation Dr Andre lev-Weissberg talks about Low Dose Naltrexone (LDN) as an immunomodulator. As a success story it modulates, it heals and restores the body to the status quo of what it was before the immune dysregulation. 

The objectives of this presentation are: